The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice

Journal of Neuroimmunology

Volumn 257, Issue 1-2, 2013, Pages 28-35

  Ma, Shuainan ^a   Zhong, Di ^a   Chen, Hongping ^a   Zheng, Yi ^a   Sun, Yanyan ^a   Luo, Jian ^a   Li, Hulun ^c   Li, Guozhong ^a   Yin, Yanhong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow stromal cell (BMSC); IL 23 IL 17 axis; Immunomodulatory; Ischemic cerebral stroke

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW STROMA CELL; BONE MARROW STROMA CELL TRANSPLANTATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MALE; MOUSE; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; STROMA CELL; THERAPY EFFECT; WESTERN BLOTTING;

ANIMALS; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; IMMUNOMODULATION; INTERLEUKIN-17; INTERLEUKIN-23; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; STROKE;

EID: 84875807977     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.01.007     Document Type: Article

References (32)

1. Aranami T., Yamamura T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 2008, 57(2008):115-120.
2. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
3. Borlongan C.V., Lind J.G., Dillion-Carter O., Yu G.L., Handman M., Cheng C., Carroll J., Hess D.C. Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier. Brain Res. 2004, 1009:26-33.
4. Bunnell B.A., Betacourt A.M., Sullivan D.E. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res. Ther. 2010, 1:34.
5. Caplan A.I. New era of cell-based orthopedic therapies. Tissue Eng. Part B Rev. 2009, 15:195-200.
6. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow Metab. 1996, 16:186-194.
7. Chen J.L., Li Y., Wang L., Zhang Z.G., Lu D.Y., Lu M., Chopp M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
8. Chen Y., Langrish C.L., Mckenzie B., Joyce B., Stumhofer J.S., McClanahan T., Blumenschein W.M., Churakova T., Low J., Presta L., Hunter C.A., Kastelein R.A., Cua D.J., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 2006, 116:1317-1326.
9. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick D.J. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
10. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
11. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
12. Fink K., Zhu J., Namura S., Shimizu-Sasamata M., Endres M., Ma J., Dalkara T., Yuan J., Moskowitz M.A. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 1999, 18:1071-1076.
13. Furuzawa-Carballeda J., Vargas-Rojas M.I., Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 2007, 6:169-175.
14. Iwakura Y., Ishigame H., Saijo S., Nakae S., et al. Functional specialization of Interleukin-17 family members. Immunity 2011, 34(2011):149-162.
15. Kawabori M., Kuroda S., Ito M., Shichinohe H., Houkin K., Kuge Y., Tamaski N., et al. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology 2012, 1440-1789.
16. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A., et al. Human TH 17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
17. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
18. Kong Q.F., Sun B., Wang G.Y., Zhai D.X., Mu L.L., Wang D.D., Wang J.H., Li R., Li H.L., et al. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. Eur. J. Immunol. 2009, 39:800-809.
19. Lambertsen K.L., Gregersen R., Meldgaard M., Clausen B.H., Heibøl E.K., Ladeby R., Knudesen J., Frandsen A., Owens T., Finsen B., et al. A role for interferon-gamma in focal cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 2004, 63:942-955.
20. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
21. Li G.Z., Zhong D., Yang L.M., Sun B., Zhong Z.H., Yin Y.H., Cheng J., Yan B.B., Li H.L., et al. Expression of interleukin-17 in ischemic brain tissue. Scand. J. Immunol. 2005, 62:481-486.
22. Matsui T., Mori T., Tateishi N., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Ikuta F., Asano T., et al. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab. 2002, 22:711-722.
23. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I., et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009, 20:419-427.
24. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and Type 17 Helper T Cells. N. Engl. J. Med. 2009, 361:888-898.
25. Prockop D.J. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol. Ther. 2009, 17(2009):939-946.
26. Raffaghello L., Bianchi G., Bertolotto M., Montecucco F., Busca A., Dallegri F., Ottonello L., Pistoia V., et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008, 26:151-162.
27. Sacco R.L., Chong J.Y., Prabhakaran S., Elkind M.S., et al. Experimental treatments for acute ischaemic stroke. Lancet 2007, 369:331-341.
28. Schnyder B., Schnyder-Candrian S., Pansky A., Schmitz M.L., Heim M., Ryffel B., Moser R., et al. IL-17 reduces TNF-induced Rantes and VCAM-1 expression. Cytokine 2005, 31:191-202.
29. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A., et al. Pivotal role of cerebral interleukin-17-producingγδ-T cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
30. Wei L., Fraser J.L., Lu Z.Y., Hu X.Y., Yu S.P., et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 2012, 46:635-645.
31. Xue Q., Luan X.Y., Gu Y.Z., Wu H.Y., Zhang G.B., Yu G.H., Zhu H.T., Wang M., Dong W., Geng Y.J., Zhang X.G., et al. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells Dev. 2010, 19:27-38.
32. Yilmaz G., Arumugam T.V., Stokes K.Y., Granger D.N., et al. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113:2105-2112.